Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation

Experimental and Toxicologic Pathology

Volumn 58, Issue 6, 2007, Pages 419-425

  Tschernig, Thomas ^a   Kiafard, Ziba ^b   Dibbert, Christian ^b   Neumann, Detlef ^a   Zwirner, Jörg ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anaphylatoxin receptor; Antibody; C3a; C5a; Complement; Immunohistochemistry; Lung

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; FROZEN SECTION; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; RAT;

ANIMALIA; MURINAE; MUS; RATTUS;

EID: 34447317234     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2007.03.004     Document Type: Article

References (27)

1. Abe M., Shibata K., Akatsu H., Shimizu N., Sakata N., Katsuragi T., et al. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J Immunol 167 (2001) 4651-4660
2. Ames R.S., Li Y., Sarau H.M., Nuthulaganti P., Foley J.J., Ellis C., et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 271 (1996) 20231-20234
3. Baelder R., Fuchs B., Bautsch W., Zwirner J., Kohl J., Hoymann H.G., et al. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J Immunol 174 (2005) 783-789
4. Bautsch W., Hoymann H.G., Zhang Q., Meier-Wiedenbach I., Raschke U., Ames R.S., et al. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J Immunol 165 (2000) 5401-5405
5. Bernier T., Tschernig T., Pabst R., Macke O., Steinmueller C., and Emmendorffer A. Effects of macrophage-CSF on pulmonary- macrophage repopulation after bone marrow transplantation. J Leukoc Biol 70 (2001) 39-45
6. Braun M.C., Reins R.Y., Li T.B., Hollmann T.J., Dutta R., Rick W.A., et al. Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol 173 (2004) 4190-4196
7. Drouin S.M., Kildsgardb J., Haviland J., Zabner J., Jia H.P., McCray P.B., et al. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 166 (2001) 2025-2032
8. Drouin S.M., Corry D.B., Hollman T.J., Kildsgaard J., and Wetsel R.A. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol 169 (2002) 5926-5933
9. Drouin S.M., Sinha M., Sfyroera G., Lambris J.D., and Wetsel R.A. A protective role for the fifth complement component (C5) in allergic airway disease. Am J Respir Crit Care Med 173 (2006) 852-857
10. Fayyazi A., Scheel O., Werfel T., Schweyer S., Oppermann M., Gotze O., et al. The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology 99 (2000) 38-45
11. Floreani A.A., Wyatt T.A., Stoner J., Sanderson S.D., Thompson E.G., Allen-Gipson D., et al. Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion. Am J Respir Cell Mol Biol 29 (2003) 472-482
12. Fregonese L., Swan F.J., van Schadewijk A., Dolhnikoff M., Santos M.A., Daha M.R., et al. Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma. J Allergy Clin Immunol 115 (2005) 1148-1154
13. Haviland D.L., McCoy R.L., Whitehead W.T., Akama H., Molmenti E.P., Brown A., et al. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 154 (1995) 1861-1869
14. Humbles A.A., Lu B., Nilsson C.A., Lilly C., Israel E., Fujiwara Y., et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406 (2000) 998-1001
15. Karp C.L., Grupe A., Schadt E., Ewart S.L., Keane-Moore M., Cuomo P.J., et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 1 (2000) 221-226
16. Kiafard Z., Tschernig T., Schweyer S., Bley A., Neumann D., and Zwirner J. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in tubular epithelial cells of human, murine and rat kidneys. Immunobiology 212 (2007) 129-139
17. Krug N., Tschernig T., Erpenbeck V.J., Hohlfeld J.M., and Kohl J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 164 (2001) 1841-1843
18. Lehmann C., Wilkening A., Leiber D., Markus A., Krug N., Pabst R., et al. Lymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune system. Anat Rec 264 (2001) 229-236
19. Melendi G.A., Hoffman S.J., Karron R.A., Irusta P.M., Laham F.R., Humbles A., et al. C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression. J Virol 81 (2007) 991-999
20. Nakano Y., Morita S., Kawamoto A., Suda T., Chida K., and Nakamura H. Elevated complement C3a in plasma from patients with severe acute asthma. J Allergy Clin Immunol 112 (2003) 525-530
21. Schmiedl A., Tschernig T., Lührmann A., and Pabst R. Leukocyte infiltration of the periarterial space of the lung after allergen provocation in a rat asthma model. Pathobiology 72 (2005) 308-315
22. Schraufstatter I.U., Trieu K., Sikora L., Sriramarao P., and DiScipio R. Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J Immunol 169 (2002) 2102-2110
23. Sohns B. Untersuchungen zur Expression des humanen C3a-Rezeptors. PhD thesis. Hannover, Germany: University of Hannover; 2000.
24. Thangam E.B., Venkatesha R.T., Zaidi A.K., Jordan-Sciutto K.L., Goncharov D.A., Krymskaya V.P., et al. Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. FASEB J 19 (2005) 798-800
25. Walport M.J. Advances in immunology: complement. N Engl J Med 344 (2001) 1058-1066
26. Weigt H., Nassenstein C., Tschernig T., Muhlradt P.F., Krug N., and Braun A. Efficacy of macrophage-activating lipopeptide-2 combined with interferon-gamma in a murine asthma model. Am J Respir Crit Care Med 172 (2005) 566-572
27. Werfel T., Zwirner J., Oppermann M., Sieber A., Begemann G., Drommer W., et al. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin. J Immunol 157 (1996) 1729-1735